Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ALGEN stock hub

EPA/ALGEN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ALGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.1M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ALGENEPA/ALGEN

—

Loading chart…

In the news

Latest news · EPA/ALGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E24.8

P25 n/aP50 n/aP75 n/a

ROE4.3

P25 n/aP50 n/aP75 n/a

ROIC3.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ALGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

EUR

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	148
Employees Change	20%
Employees Change Percent	15.63
Enterprise value	EUR 29.8M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0004053510
Last refreshed	2026-05-10
Market cap	EUR 23.1M
Price	EUR 2.5
Price currency	EUR
Rev Per Employee	141,594.59x
Sector	Healthcare
Sic	2835
Symbol	epa/ALGEN
Website	https://www.genoway.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.03%
EV Earnings	32.08x
EV/EBIT	19.41x
EV/Sales	1.42x
P/B ratio	0.92x
P/E ratio	24.84x
P/S ratio	1.1x
PE Ratio10 Y	43.98x
PE Ratio3 Y	22.39x
PE Ratio5 Y	23.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.32%
Gross margin	100%
Gross Profit	EUR 21M
Gross Profit Growth	42%
Gross Profit Growth Q	79.32%
Gross Profit Growth3 Y	10.05%
Gross Profit Growth5 Y	9.76%
Net Income	EUR 928,000
Net Income Growth	-49.31%
Net Income Growth Q	-31.91%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.6%
Net Income Growth5 Y	-10.26%
Pretax Margin	5.96%
Profit Margin	4.43%
Profit Per Employee	EUR 6,270
Profitable Years	4
ROA	2.49
Roa5y	1.56
ROCE	3.61
ROE	4.26
Roe5y	5.22
ROIC	3.6
Roic5y	3.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.5%
Cagr15y	-1.12%
Cagr1y	-18.04%
Cagr3y	-12.33%
Cagr5y	-7.94%
EPS Growth Years	0
Revenue Growth	-23.88x
Revenue Growth Q	-43.41x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-9.3x
Revenue Growth5 Y	-1.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.54
Assets	EUR 45.4M
Cash	EUR 7.1M
Current Assets	EUR 23.2M
Current Liabilities	EUR 2.8M
Debt	EUR 13.8M
Debt Equity	EUR 0.55
Equity	EUR 25M
Interest Coverage	5.38
Liabilities	EUR 20.4M
Long Term Assets	EUR 22.2M
Long Term Liabilities	EUR 17.6M
Net Cash	EUR -6.7M
Net Cash By Market Cap	EUR -29.14
Net Debt Equity	EUR 0.27
Tangible Book Value	EUR 18.4M
WACC	4.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.26
Net Working Capital	EUR 13.3M
Quick ratio	5.68
Working Capital	EUR 20.4M
Working Capital Turnover	EUR 1.43

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	55.28%
1Y total return	-18.03%
200-day SMA	2.64
3Y total return	-32.61%
50-day SMA	2.43
50-day SMA vs 200-day SMA	50under200
5Y total return	-33.86%
All Time High	7.75
All Time High Change	-67.74%
All Time High Date	2007-05-29
All Time Low	0.84
All Time Low Change	197.62%
All Time Low Date	2009-02-02
ATR	0.08
Beta	0.4
Beta1y	-0.37
Beta2y	0.23
Ch YTD	-7.75
High	2.72
High52	3.5
High52 Date	2025-06-19
High52ch	-28.57%
Low	2.43
Low52	2.1
Low52 Date	2025-11-18
Low52ch	19.05%
Ma50ch	2.71%
Price vs 200-day SMA	-5.27%
RSI	55.73
RSI Monthly	37.28
RSI Weekly	46.32
Sharpe ratio	-0.41x
Sortino ratio	-0.51
Tr YTD	-7.75
Tr15y	-15.54%
Tr1m	1.22%
Tr1w	1.63%
Tr3m	0.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.5M
Operating Income Growth	99.97
Operating Income Growth Q	93.6
Operating Income Growth3 Y	6.75
Operating Income Growth5 Y	3.98
Operating margin	7.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	9,220,171

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,539.3x
Ch10y	55.28
Ch15y	-15.54
Ch1m	1.22
Ch1w	1.63
Ch1y	-18.03
Ch3m	0.4
Ch3y	-32.61
Ch5y	-33.86
Ch6m	0.81
Change	2.88%
Change From Open	2.88
Close	2.43
Days Gap	0
Dollar Volume	122,212.5
Earnings Date	2026-04-02
EBIT	EUR 1.5M
F Score	4
Fiscal Year End	December
Founded	1,999
Income Tax	EUR 321,000
Is Primary Listing	1
Last Earnings Date	2025-12-24
Last Report Date	2025-12-31
Ma150	2.53
Ma150ch	-1.07%
Ma20	2.46
Ma20ch	1.79%
Open	2.43
Position In Range	24.14
Ppne	12,511,000
Price Date	2026-05-08
Ptbv Ratio	1.25
Relative Volume	15.32x
Revenue	20,956,000x
Tax By Revenue	1.53x
Tax Rate	25.7%
Tr6m	0.81%
Volume	48,885

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ALGEN pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ALGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

EPA/ALGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.7

Neutral momentum band

Price vs 200-day MA

-5.3%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ALGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ALGEN stock rating?

epa/ALGEN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ALGEN analysis?

The full report lives at /stocks/epa/ALGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ALGEN?

The latest report frames epa/ALGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ALGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.